SeekPeptides exists to give you exactly that, an honest, research-backed look at what actually matters when choosing a GLP-1 provider
J Clin Epidemiol 134:A5A6 Vo TTT et al (2020) The promising role of antioxidant phytochemicals in the prevention and treatment of periodontal disease via the inhibition of oxidative stress pathways: updated insights
Liver Disease: MASLD and NAFLD Metabolic dysfunction-associated steatotic liver disease (MASLD formerly NAFLD) affects approximately 1 in 3 UK adults with obesity
The 2023 phase 2 double-blind, randomized controlled trial evaluating a GLP-1/GIP/glucagon receptor triagonist (retatrutide) in patients with the disease of obesity reported 24.2% weight loss at 48 weeks with 12 mg retatrutide
The cardioprotective properties, weight loss, and blood glucose control can be significant
Your provider can sequence antibiotic timing, adjust doses if needed, and watch for unexpected side effects